ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dexpramipexole attenuates myocardial ischemia/reperfusion injury through upregulation of mitophagy

Tang, Lu; Li, Yun-peng; Hu, Juan; Chen, Ai-hua*; Mo, Yingli*南方医科大学; 郑州大学; 1
European Journal of Pharmacology2021-5-15DOI: 10.1016/j.ejphar.2021.173962
14被引8阅读
引用收藏
分享

摘要

Reperfusion causes undesirable damage to the ischemic myocardium while restoring the blood flow. In this study, we evaluated the effects of dexpramipexole (DPX) on myocardial injury induced by ischemia/reperfusion (I/R) in-vivo and the hypoxia/reoxygenation (HR) in-vitro and examined the functional mechanisms of DPX. DPX protected cells against H/R-induced mitochondrial dysfunction and prevented H/R damage. Both myocardial infarct size and tissue damage due to I/R was reduced upon DPX treatment. We discovered that DPX enhanced mitophagy in-vivo and in-vitro, which was accompanied by enhanced expression of PINK1 and Parkin. Knockdown of PINK1 and Parkin by specific siRNAs reversed DPX-induced inhibition of myocardial I/R injury. These findings suggest that DPX might protect against myocardial injury via PINK1 and Parkin.

学科与关键词

关键词
MitophagyIschemiaReperfusionMyocardialDexpramipexole
相关
加载中…
  • RETRACTED: Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis (Retracted Article)
    Zhang, Xiong; Li, Yongxing; Wang, Yong; Zhuang, Yuerong; Ren, Xiaojie; Yang, Kai; Ma, Wuhua*; Zhong, Ming*Bioscience Reports, 2020, 40: BSR20194030.被引 19
  • Daming capsule protects against myocardial infarction by promoting mitophagy via the SIRT1/AMPK signaling pathway
    Sun, Xi; Han, Yanna; Dong, Chaorun; Qu, Huan; Yu, Yahan; Ju, Jiaming; Bai, Yunlong*; Yang, Baofeng*Biomedicine and Pharmacotherapy, 2022, 151: 113162.被引 4
  • Metformin Collaborates with PINK1/Mfn2 Overexpression to Prevent Cardiac Injury by Improving Mitochondrial Function
    Ma, Zhuang; Liu, Zuheng; Li, Xudong; Zhang, Hao; Han, Dunzheng; Xiong, Wenjun; Zhou, Haobin; Yang, Xi; Zeng, Qingchun; Ren, Hao*; Xu, Dingli*Biology-Basel, 2023, 12(4): 582.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
European Journal of Pharmacology
发表日期
2021-05-15
卷期
第 899 卷
页码
173962
DOI
10.1016/j.ejphar.2021.173962
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation [2020T130143ZX]; Scientific and Technological Research Project of the Education Department in Hunan Province in China [18B589]

作者

  • T

    Tang, Lu (第一作者)

  • L

    Li, Yun-peng

    1 · zhengzhou univ · southern med univ

查看全部 5 位作者收起作者
  • H

    Hu, Juan

  • C

    Chen, Ai-hua (通讯)

    southern med univ

  • M

    Mo, Yingli (通讯)

    hunan univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417